These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review. Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489 [TBL] [Abstract][Full Text] [Related]
9. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341 [TBL] [Abstract][Full Text] [Related]
10. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297 [TBL] [Abstract][Full Text] [Related]
11. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre. Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364 [TBL] [Abstract][Full Text] [Related]
12. Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study. Cassone G; Manfredi A; Atzeni F; Venerito V; Vacchi C; Picerno V; Furini F; Erre GL; Tomietto P; Fedele AL; Della Casa G; Nucera V; Giannitti C; Salvarani C; Sebastiani M J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963908 [TBL] [Abstract][Full Text] [Related]
13. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Manfredi A; Cassone G; Furini F; Gremese E; Venerito V; Atzeni F; Arrigoni E; Della Casa G; Cerri S; Govoni M; Petricca L; Iannone F; Salvarani C; Sebastiani M Intern Med J; 2020 Sep; 50(9):1085-1090. PubMed ID: 31661185 [TBL] [Abstract][Full Text] [Related]
14. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Yuan H; Cui S; Yang L; Cui J; Wang X; Ding M; Jin L; Wang Y; Chang F; Jin H; Ma J; Shi M; Liu A RMD Open; 2023 Oct; 9(4):. PubMed ID: 37899093 [TBL] [Abstract][Full Text] [Related]
18. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression. Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866 [TBL] [Abstract][Full Text] [Related]